Literature DB >> 17426996

Apolipoprotein E epsilon4 genotype is independently associated with increased intima-media thickness in a recessive pattern.

M Wohlin1, J Sundström, Lars Lannfelt, Tomas Axelsson, A C Syvänen, B Andrén, S Basu, L Lind.   

Abstract

Polymorphisms in the apolipoprotein E (Apo E) gene have been associated with lipid levels, carotid intima media thickness (CCA-IMT), inflammation and cardiovascular disease (CVD). Earlier findings suggested an association of the Apo E alleles with increased CCA-IMT following a recessive pattern. Whether associations might be independent of C-reactive protein (CRP), lipid levels and other CVD risk factors is not known. We investigated the relationships between Apo E (epsilon2, epsilon3 and epsilon4 alleles) and CCA-IMT, measured by B-mode ultrasound, in dominant and recessive models in a community-based sample of 437 men 75 years of age. In men homozygous for the epsilon4 allele CCA-IMT was significantly increased by 0.13 mm to 0.86 +/- 0.16 mm compared to 0.73 +/- 0.19 mm in non- epsilon4-carriers (P = 0.0012) and 0.73 +/- 0.21 mm in epsilon4 heterozygous (P = 0.0044) in unadjusted recessive models. The association between Apo E epsilon4 genotype and CCA-IMT was independent of Apo E epsilon2 and Apo E epsilon3 alleles, CRP, lipid variables (TG, LDL, HDL) and other CVD risk factors (smoking, hypertension, body mass index, diabetes) (P = 0.018). No relations between Apo E genotype and CCA-IMT were observed in dominant models. No significant associations between the Apo E epsilon2 and epsilon3 alleles and CCA-IMT were found. In this study, men homozygous with the ApoE epsilon4 allele had thicker CCA-IMT, independently of Apo E epsilon2 and epsilon3 alleles, CRP, lipid variables (TG, LDL, HDL) and other CVD risk factors (smoking, hypertension, body mass index, diabetes), suggesting CCA-IMT to be modified by the ApoE epsilon4 genotype in a recessive pattern.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17426996     DOI: 10.1007/s11745-007-3045-5

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.646


  39 in total

1.  Universal SNP genotyping assay with fluorescence polarization detection.

Authors:  T M Hsu; X Chen; S Duan; R D Miller; P Y Kwok
Journal:  Biotechniques       Date:  2001-09       Impact factor: 1.993

2.  Divergent association of apolipoprotein E polymorphism with vascular disease in patients with NIDDM and control subjects.

Authors:  I Vauhkonen; L Niskanen; M Ryynänen; R Voutilainen; J Partanen; J Töyry; M Mercuri; R Rauramaa; M Uusitupa
Journal:  Diabet Med       Date:  1997-09       Impact factor: 4.359

3.  Apolipoprotein E polymorphism affects carotid artery atherosclerosis in smoking hypertensive men.

Authors:  Jarkko Karvonen; Heikki Kauma; Kari Kervinen; Olavi Ukkola; Maire Rantala; Markku Päivänsalo; Markku J Savolainen; Y Antero Kesäniemi
Journal:  J Hypertens       Date:  2002-12       Impact factor: 4.844

4.  The independent correlation of the impact of lipoprotein(a) levels and apolipoprotein E polymorphism on carotid artery intima thickness.

Authors:  B Horejsí; J Spácil; R Ceska; M Vrablík; T Haas; A Horínek
Journal:  Int Angiol       Date:  2000-12       Impact factor: 2.789

Review 5.  A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors.

Authors:  Koon Sung Cheng; Dimitri P Mikhailidis; George Hamilton; Alexander M Seifalian
Journal:  Cardiovasc Res       Date:  2002-06       Impact factor: 10.787

6.  Apolipoprotein E polymorphism and carotid artery intima-media thickness in a random sample of middle-aged men.

Authors:  E Ilveskoski; A Loimaala; M F Mercuri; T Lehtimäki; M Pasanen; A Nenonen; P Oja; M G Bond; T Koivula; P J Karhunen; I Vuori
Journal:  Atherosclerosis       Date:  2000-11       Impact factor: 5.162

7.  Association of APOE genotype with carotid atherosclerosis in men and women: the Framingham Heart Study.

Authors:  Roberto Elosua; Jose M Ordovas; L Adrienne Cupples; Caroline S Fox; Joseph F Polak; Philip A Wolf; Ralph A D'Agostino; Christopher J O'Donnell
Journal:  J Lipid Res       Date:  2004-07-16       Impact factor: 5.922

8.  Apolipoprotein E polymorphism is associated with segment-specific extracranial carotid artery intima-media thickening.

Authors:  J G Terry; G Howard; M Mercuri; M G Bond; J R Crouse
Journal:  Stroke       Date:  1996-10       Impact factor: 7.914

Review 9.  Ultrasound B-mode imaging in observational studies of atherosclerotic progression.

Authors:  J T Salonen; R Salonen
Journal:  Circulation       Date:  1993-03       Impact factor: 29.690

10.  Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia.

Authors:  Y Huang; X Q Liu; S C Rall; J M Taylor; A von Eckardstein; G Assmann; R W Mahley
Journal:  J Biol Chem       Date:  1998-10-09       Impact factor: 5.157

View more
  5 in total

1.  LCAT cholesterol esterification is associated with the increase of ApoE/ApoA-I ratio during atherosclerosis progression in rabbit.

Authors:  Alessandro Carlucci; Luisa Cigliano; Bernardetta Maresca; Maria Stefania Spagnuolo; Giovanni Di Salvo; Raffaele Calabrò; Paolo Abrescia
Journal:  J Physiol Biochem       Date:  2012-05-05       Impact factor: 4.158

2.  Association between apolipoprotein E polymorphism and subclinic atherosclerosis in patients with type 1 diabetes mellitus.

Authors:  Mehmet Emre Atabek; Yusuf Özkul; Beray Selver Eklioğlu; Selim Kurtoğlu; Murat Baykara
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-03

3.  Identification of a novel proinsulin-associated SNP and demonstration that proinsulin is unlikely to be a causal factor in subclinical vascular remodelling using Mendelian randomisation.

Authors:  Rona J Strawbridge; Angela Silveira; Marcel den Hoed; Stefan Gustafsson; Jian'an Luan; Denis Rybin; Josée Dupuis; Ruifang Li-Gao; Maryam Kavousi; Abbas Dehghan; Kadri Haljas; Jari Lahti; Jesper R Gådin; Alexandra Bäcklund; Ulf de Faire; Karl Gertow; Phillipe Giral; Anuj Goel; Steve E Humphries; Sudhir Kurl; Claudia Langenberg; Lars L Lannfelt; Lars Lind; Cecilia C M Lindgren; Elmo Mannarino; Dennis O Mook-Kanamori; Andrew P Morris; Renée de Mutsert; Rainer Rauramaa; Peter Saliba-Gustafsson; Bengt Sennblad; Andries J Smit; Ann-Christine Syvänen; Elena Tremoli; Fabrizio Veglia; Björn Zethelius; Hanna M Björck; Johan G Eriksson; Albert Hofman; Oscar H Franco; Hugh Watkins; J Wouter Jukema; Jose C Florez; Nicholas J Wareham; James B Meigs; Erik Ingelsson; Damiano Baldassarre; Anders Hamsten
Journal:  Atherosclerosis       Date:  2017-09-28       Impact factor: 5.162

4.  GWAS-identified loci for coronary heart disease are associated with intima-media thickness and plaque presence at the carotid artery bulb.

Authors:  Marcel den Hoed; Rona J Strawbridge; Peter Almgren; Stefan Gustafsson; Tomas Axelsson; Gunnar Engström; Ulf de Faire; Bo Hedblad; Steve E Humphries; Cecilia M Lindgren; Andrew P Morris; Gerd Östling; Ann-Christine Syvänen; Elena Tremoli; Anders Hamsten; Erik Ingelsson; Olle Melander; Lars Lind
Journal:  Atherosclerosis       Date:  2015-01-31       Impact factor: 5.162

Review 5.  Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals.

Authors:  Tauseef A Khan; Tina Shah; David Prieto; Weili Zhang; Jackie Price; Gerald R Fowkes; Jackie Cooper; Philippa J Talmud; Steve E Humphries; Johan Sundstrom; Jaroslav A Hubacek; Shah Ebrahim; Debbie A Lawlor; Yoav Ben-Shlomo; Mohammad R Abdollahi; Arjen J C Slooter; Zoltan Szolnoki; Manjinder Sandhu; Nicholas Wareham; Ruth Frikke-Schmidt; Anne Tybjærg-Hansen; Gerda Fillenbaum; Bastiaan T Heijmans; Tomohiro Katsuya; Grazyna Gromadzka; Andrew Singleton; Luigi Ferrucci; John Hardy; Bradford Worrall; Stephen S Rich; Mar Matarin; John Whittaker; Tom R Gaunt; Peter Whincup; Richard Morris; John Deanfield; Ann Donald; George Davey Smith; Mika Kivimaki; Meena Kumari; Liam Smeeth; Kay-Tee Khaw; Michael Nalls; James Meschia; Kai Sun; Rutai Hui; Ian Day; Aroon D Hingorani; Juan P Casas
Journal:  Int J Epidemiol       Date:  2013-04       Impact factor: 7.196

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.